UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Xylo10-Adr5-InjSol-SE-AJ-RA

Generated Narrative: RegulatedAuthorization Xylo10-Adr5-InjSol-SE-AJ-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/8318

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001718-00008318,http://ema.europa.eu/fhir/eurdId#1233; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection; indication = Infiltrationsanestesi, perifera nervblockader, terapeutiska och diagnostiska blockader, epiduralanestesi. Xylocain adrenalin är avsett för vuxna och barn över 1 år.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = lidocaine, combinations

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 1968-10-25

holder: Organization Aspen Pharma Trading Limited

Cases

-TypeDate[x]
*First Authorisation1968-10-25